Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000130220 | SCV000185059 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-10-12 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Insufficient or conflicting evidence |
Counsyl | RCV000111765 | SCV000487950 | uncertain significance | Breast-ovarian cancer, familial 1 | 2015-12-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000440541 | SCV000520968 | likely benign | not specified | 2017-09-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color | RCV000130220 | SCV000906721 | benign | Hereditary cancer-predisposing syndrome | 2016-11-21 | criteria provided, single submitter | clinical testing | |
Breast Cancer Information Core |
RCV000111765 | SCV000144295 | uncertain significance | Breast-ovarian cancer, familial 1 | 1999-04-06 | no assertion criteria provided | clinical testing | |
3DMed Clinical Laboratory Inc | RCV000677807 | SCV000803966 | uncertain significance | Neoplasm of the breast | 2017-09-05 | no assertion criteria provided | clinical testing |